Effect of naloxone on cognitive function in vascular dementia in rats

Indian Journal of Medical Research

Volumn 115, Issue JUNE, 2002, Pages 265-271

  Sun, Shi Lei ^a   Xu, Xiao Hu ^a   Ma, Guang Yu ^a   Xu Hong, ^a  

^a SHANTOU UNIVERSITY   (China)

Author keywords

Hippocampus; Learning and memory; Long term potentiation; Morris water maze; Naloxone; Vascular dementia

Indexed keywords

NALOXONE; OPIATE; OPIATE RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; BRAIN SLICE; COGNITION; COGNITIVE DEFECT; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; ESCAPE BEHAVIOR; EXTRACELLULAR SPACE; HIPPOCAMPUS; LATENT PERIOD; LEARNING; LONG TERM POTENTIATION; MALE; MAZE TEST; MEMORY DISORDER; MULTIINFARCT DEMENTIA; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NONHUMAN; PYRAMIDAL NERVE CELL; RAT; RECORDING; SENILE DEMENTIA; SPATIAL MEMORY; STATISTICAL SIGNIFICANCE; SYNAPSE;

ANIMALS; COGNITION; DEMENTIA, VASCULAR; ELECTROPHYSIOLOGY; HIPPOCAMPUS; HUMANS; LONG-TERM POTENTIATION; MAZE LEARNING; NALOXONE; NARCOTIC ANTAGONISTS; RATS; TIME FACTORS;

EID: 0036592228     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Barclay LL, Zemcov A, Blass JP, Sansone J. Survival in Alzheimer's disease and vascular dementia. Neurology 1985; 35 : 834-40.
2. Cleary J, Semotuk M, Levine AS. Effects of neuropeptide Y on short-term memory. Brain Res 1994; 653 : 210-4.
3. Ukai M, Watanabe Y, Kameyama T. Endomorphins 1 and 2, endogenous μ-opioid receptor agonists, impair passive avoidance learning in mice. Eur J Pharmacol 2001; 421 : 115-9.
4. Rigter H, Hannan TJ, Messing RB, Martinez JL Jr, Vasquez BJ, Jensen RA, et al. Enkephalins interfere with acquisition of an active avoidance response. Life Sci 1980; 26 : 337-45.
5. Sollertinskaya TN. Comparative study of the roles of ACTH and β-endorphin in regulating conditioned reflex activity in the hedgehog. Neurosci Behav Physiol 1997; 27 : 663-71.
6. Netto CA, Maltchik M. Distinct mechanisms underlying memory modulation after the first and the second session of two avoidance tasks. Behav Neural Biol 1990; 53 : 29-38.
7. Mathieu-Kia AM, Fan FQ, Kreek MJ, Simon EJ, Hiller JM. μ-, δ- and κ-opioid receptor populations are differentially altered in distinct area of postmortem brains of Alzheimer's disease patients. Brain Res 2001; 893 : 121-34.
8. Sundar KS, Kamaraju LS, Dingfelder J, McMahon J, Gollapudi S, Wilson WH, et al. Beta-endorphin enhances the replication of neurotropic human immunodeficiency virus in fetal perivascular microglia. J Neuroimmunol 1995; 61 : 97-104.
9. Reisberg B, Ferris SH, Anand R, Mir P, Geibel V, de Leon MJ. Effects of naloxone in senile dementia: A double-blind trial. N Engl J Med 1983; 308 : 721-2.
10. Akhondzadeh S. Hippocampal synaptic plasticity and cognition. J Clin Pharm Ther 1999; 24 : 241-8.
11. Ni JW, Ohta H, Matsumoto K, Watanabe H. Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats. Brain Res 1994; 653 : 231-6.
12. Conway EL. Brain lesions and delayed water maze learning deficits after intracerebroventricular spermine. Brain Res 1998; 800 : 10-20.
13. D'Hooge R, Van Dam D, Franck F, Gieselmann V, De Deyn PP. Hyperactivity, neuromotor defects, and impaired learning and memory in a mouse model for metachromatic leukodystrophy. Brain Res 2001; 907 : 35-43.
14. Matsuoka N, Satoh M. FK960, a novel potential anti-dementia drug, auguments long-term potentiation in mossy fiber-CA3 pathway of guinea-pig hippocampal slices. Brain Res 1998; 794 : 248-54.
15. Nanri M, Watanabe H. Availability of 2VO rats as a model for chronic cerebrovascular disease. Nippon Yakurigaku Zasshi 1999; 113 : 85-95.
16. de la Torre JC, Fortin T, Park GAS, Bulter KS, Kozlowski P, Pappas BA, et al. Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats. Brain Res 1992; 582 : 186-95.
17. Bliss TVP, Lynch MA. Long-lasting potentiation of synaptic transmission in the hippocampus : properties and mechanisms. In : Landfield PW, Deadwyler SA, editors. Long-term potentiation from biophysics to behaviour. New York : Alan R. Liss; 1988 p. 3-72.
18. Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361 : 31-9.
19. Barria A, Muller D, Derkach V, Griffith LC, Soderling TR. Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science 1977; 276 : 2042-45.
20. Silva AJ, Paylor R, Wehner JM, Tonegawa S. Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science 1992; 257 : 206-11.
21. Teyler TJ, Discenna P. Long-term potentiation as a candidate mnemonic device. Brain Res Rev 1984; 7 : 15-28.
22. Morris BJ, Johnston HM. A role for hippocampal opioids in long-term functional plasticity. Trends Neurosci 1995; 18 : 350-5.
23. Terman GW, Wanger JJ, Chavkin C. Kappa opioids inhibit induction of long-term potentiation in the dentate gyrus of the guinea pig hippocampus. J Neurosci 1994; 14 : 4740-7.
24. Hosobuchi Y, Baskin DS, Woo SK. Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone. Science 1982; 215 : 69-71.
25. McIntosh TK, Fernyak S, Hayes RL, Faden AI. Beneficial effect of the nonselective opiate antagonist naloxone hydrochloride and the thyrotropin-releasing hormone (TRH) analog YM-14673 on long-term neurobehavioral outcome following experimental brain injury in the rat. J Neurotrauma 1993; 10 : 373-84.
26. Cain DP, Saucier D, Boon F. Testing hypotheses of spatial learning: the role of NMDA receptors and NMDA-mediated long-term potentiation. Behav Brain Res 1997; 84 : 179-93.